Florian Buchkremer
@swissnephro.bsky.social
750 followers
370 following
45 posts
Nephrologist. Views are my own. #UrinarySediment #Hyponatremia #POCUS
👉 www.swissnephro.org
Posts
Media
Videos
Starter Packs
Pinned
Reposted by Florian Buchkremer
Reposted by Florian Buchkremer
josh farkas 💊
@pulmcrit.bsky.social
· Jun 10
Viewpoint: The US FDA aims to expedite drug approvals and address childhood chronic diseases by leveraging innovation, food safety, #AI, and big data.
ja.ma/45jWnNS #MedSky
ja.ma/45jWnNS #MedSky
Reposted by Florian Buchkremer
Michael Walsh
@lastwalsh.bsky.social
· Jun 5
The Aldosterone Blockade for Health Improvement Evaluation in End-Stage Renal Disease (ACHIEVE) Trial: Rationale and Clinical Research Protocol - Michael Walsh, David Collister, Martin Gallagher, Patr...
Background: The mineralocorticoid aldosterone may contribute to the risk of cardiovascular morbidity and mortality in patients receiving maintenance dialysis. W...
journals.sagepub.com
Reposted by Florian Buchkremer
Reposted by Florian Buchkremer
Reposted by Florian Buchkremer
Reposted by Florian Buchkremer
Reposted by Florian Buchkremer
🧵 Introducing the EQUIL2 Urinary Supersaturation Calculator
A powerful web-based tool for nephrologists and researchers to assess kidney stone risk with ease. Based on the validated EQUIL2 algorithm from peer-reviewed scientific literature.
ukidney.com/calculators/...
1/3
A powerful web-based tool for nephrologists and researchers to assess kidney stone risk with ease. Based on the validated EQUIL2 algorithm from peer-reviewed scientific literature.
ukidney.com/calculators/...
1/3
EQUIL2 - Urinary Supersaturation Calculator
Calculate urinary supersaturation based on EQUIL2 methodology.
ukidney.com
Reposted by Florian Buchkremer
Reposted by Florian Buchkremer
Katie Wiskar
@katiewiskar.bsky.social
· Feb 25
Reposted by Florian Buchkremer
StockTitan
@stocktitan.net
· Feb 3
Revolutionary Pig-to-Human Kidney Transplant Trial Gets Historic FDA Green Light
United Therapeutics advances xenotransplantation with FDA clearance for UKidney™ human trials, offering hope to 557,000+ dialysis patients. First transplants planned for 2025.
www.stocktitan.net
Reposted by Florian Buchkremer